AnalystsDavid HoangDavid Hoang's Stock Forecasts
AnalystsDavid Hoang
Sectors:
Analyst Ranking
Bottom 11%
#4072 out of 4565 analysts
Average Return
-13.63%
Win Rate
15%2 out of 13
Risk vs Reward
Poor
Good
David Hoang Analyst Color
Get additional color on David Hoang's coverage of popular stocks
David Hoang's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Axsome Therapeutics IncAXSM | 2 | Strong Buy | $127.00 | +77.57% | Maintains | a month ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $16.00 | +87.35% | Initiates Coverage On | a month ago |
Acadia Pharmaceuticals IncACAD | 2 | Strong Buy | $30.19 | +85.10% | Maintains | a month ago |
Voyager Therapeutics IncVYGR | 1 | Strong Buy | $16.00 | +115.63% | Initiates Coverage On | 2 months ago |
Sarepta Therapeutics IncSRPT | 3 | Strong Buy | $172.00 | +35.02% | Maintains | 2 months ago |
Longboard Pharmaceuticals IncLBPH | 1 | Strong Buy | $40.00 | +107.79% | Initiates Coverage On | 2 months ago |
Neurocrine Biosciences IncNBIX | 2 | Hold | $140.00 | +1.63% | Maintains | 3 months ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $62.00 | +54.61% | Initiates Coverage On | 4 months ago |
Denali Therapeutics IncDNLI | 1 | Strong Buy | $32.00 | +113.90% | Initiates Coverage On | 4 months ago |
Alnylam Pharmaceuticals IncALNY | 1 | Hold | $220.00 | N/A | Initiates Coverage On | a year ago |
Arrowhead Pharmaceuticals IncARWR | 1 | Buy | $80.00 | N/A | Initiates Coverage On | a year ago |
Provention Bio IncPRVB | 1 | Hold | $25.00 | N/A | Downgrades | a year ago |
Gossamer Bio IncGOSS | 1 | Hold | $3.00 | N/A | Downgrades | a year ago |
Orchard Therapeutics PLCORTX | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.